Welcome to our dedicated page for SOY news (Ticker: SOY), a resource for investors and traders seeking the latest updates and insights on SOY stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect SOY's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of SOY's position in the market.
SunOpta reported Q4 2020 financial results with revenues of $205.6 million, up 10.4% from $186.1 million in Q4 2019. Gross margin improved to 15.5%, from 11.9% a year earlier. The company's earnings reached $70.2 million or $0.78 per share, a recovery from a loss of $7.6 million in Q4 2019. Adjusted EBITDA rose to $20.6 million, or 10.0% of revenues. However, a net loss from continuing operations amounted to $34.3 million. The balance sheet strengthened significantly, with total debt decreasing from $480 million to $69.7 million post the divestiture of Tradin Organic.
SunOpta Inc. (Nasdaq:STKL, TSX:SOY) announced it will report its fourth quarter 2020 financial results before markets open on March 3, 2021. A conference call is scheduled for 9:00 AM ET, following the results release, which will include a Q&A session for investors. Interested parties can join via a live webcast or pre-register for a telephone line through SunOpta's website. The company is known for specializing in organic, natural, and non-GMO plant-based food and beverage products.
SunOpta Inc. (Nasdaq:STKL) announced that Oaktree Capital Management will exchange all Series A Preferred Shares for common stock, representing 12.3% of outstanding shares post-exchange, effective around February 17, 2021. Oaktree initially invested $85 million in 2016, with an 8% annual dividend of $7 million. After the exchange, Oaktree will control 19% of voting shares and keep rights to nominate two board members. CEO Joe Ennen highlighted Oaktree's partnership in accelerating growth.
SunOpta Inc. (Nasdaq:STKL, TSX:SOY) announces a strategic investment in its Plant-Based Foods and Beverages segment, aimed at expanding the capacity of its Allentown, Pennsylvania plant. This follows three significant projects in 2020, with expectations for new capacity to be operational by Q4 2021. Additionally, the company is closing its frozen fruit processing plant in Santa Maria, California, effective February 1, 2021, to streamline operations and reduce costs, while maintaining relationships with growers. These actions are part of a broader optimization strategy to enhance profitability.
SunOpta announced the successful sale of its global ingredients segment to Amsterdam Commodities for €330 million, closing on December 30, 2020. This strategic divestiture aims to enhance SunOpta’s positioning in the plant-based market and reduce debt. The company secured a new credit facility of $250 million, with an additional $75 million term loan for capital expenditures. The retirement of $223.5 million in second lien notes is expected to reduce interest expenses by approximately $21 million annually, significantly improving the company's financial stability and operational flexibility.
